McCarter & English, LLP
Piperazine derivatives as liver X receptor modulators
Provided are novel compounds of Formula (I): pharmaceutically acceptable salts thereof, and pharmaceutical compositions thereof, which are liver X receptor modulators, and which are useful in the treatment of diseases and disorders associated with the liver X receptor. Also provided are the compounds of Formula (I) and pharmaceutical compositions thereof for treating atherosclerosis, cardiovascular disease, Alzheimer's disease, dermatitis, dyslipidemia, cancer and other diseases or disorders.
Vitae Pharmaceuticals, Inc.
A C A C A C A A A C A C A C C A A A A C C A A C A A C C A A A A A
A61P C07D A61P C07D A61P C07D A61P A61P A61P C07D A61P C07D A61P C07D C07D A61P A61P A61P A61P C07D C07D A61P A61P C07D A61P A61P C07D C07D A61P A61P A61P A61P A61P
inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional
Katerina Suresh B. Chengguo Colin M. David A. Yi Yajun Wei Stephen D. Linghang
Leftheris Singh Dong Tice Claremon Fan Zheng Zhao Lotesta Zhuang